STOCK TITAN

RDNT insider Form 144: 5,000 common shares proposed sale on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RadNet, Inc. (RDNT) Form 144 notice: The filer proposes to sell 5,000 shares of common stock through Raymond James (9595 Wilshire Blvd., Suite 801, Beverly Hills, CA) with an approximate aggregate market value of $358,950. The proposed sale date is 08/27/2025 on NASDAQ. The filing reports 76,916,062 shares outstanding. All 5,000 shares were acquired as stock awards from the issuer on 01/28/2021 (864 shares), 02/18/2021 (1,205 shares) and 01/05/2022 (2,931 shares), and payment/nature of acquisition is listed as Stock Award. The form contains no reportable sales in the past three months. Several standard filer and issuer identification fields (CIK, issuer name and contact details) are not provided in the visible content.

Positive

  • Full disclosure of acquisition history: all 5,000 shares are documented with acquisition dates and noted as stock awards
  • Broker and sale logistics provided: broker named (Raymond James), proposed sale date (08/27/2025) and exchange (NASDAQ) listed

Negative

  • Missing filer and issuer identifiers: CIK and issuer name/contact details are not present in the provided content, limiting verification
  • No recent sales detail: while the form states "Nothing to Report" for past three months, absence of linked Form 4 references reduces traceability

Insights

TL;DR Routine insider sale notice for 5,000 shares, aggregated from prior stock awards; not clearly material to company valuation.

The filing documents a proposed Rule 144 sale of 5,000 common shares with a stated aggregate market value of $358,950, scheduled for 08/27/2025 through Raymond James. The shares were all acquired as stock awards across 2021–2022, which confirms the sale consists of vested compensation shares rather than newly purchased stock. No recent sales in the past three months are reported. Given the company's reported 76.9 million shares outstanding, the sale represents a small fraction of float and appears routine. Missing filer/issuer identifiers limit cross-referencing against other insider activity.

TL;DR Disclosure meets Rule 144 structure but lacks complete filer/issuer identifiers in the provided text, which hinders verification.

The notice includes the required elements for a Rule 144 disclosure: class of security, broker name, number of shares, aggregate value, acquisition dates and nature (stock awards), and proposed sale date and venue. The signer asserts no undisclosed material adverse information. However, the visible content omits explicit filer CIK and issuer name details, which are important for compliance checks and for matching this filing to other SEC disclosures or Form 4 filings. As presented, the notice appears procedurally routine but verification requires the missing identifiers.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does the RadNet (RDNT) Form 144 propose to sell?

The notice proposes sale of 5,000 common shares of RadNet.

When is the proposed sale date on the Form 144 for RDNT?

The proposed approximate date of sale is 08/27/2025.

Through which broker will the RDNT shares be sold?

The broker listed is Raymond James (9595 Wilshire Blvd., Suite 801, Beverly Hills, CA).

How were the 5,000 RDNT shares acquired?

All shares were acquired as stock awards: 864 on 01/28/2021, 1,205 on 02/18/2021, and 2,931 on 01/05/2022.

What is the aggregate market value and outstanding shares reported?

Aggregate market value is stated as $358,950 and shares outstanding are listed as 76,916,062.

Does the filing report any securities sold in the past three months?

The filing indicates "Nothing to Report" for securities sold during the past three months.
Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

5.62B
66.81M
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES